Cogent Biosciences
Price & Volume
Stats
See more52W Range | $3.72-$14.54 |
Market Cap | $1.9B |
Shares Short | 15M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$121.6M |
Diluted EPS | -$2.05 |
News
See moreYahoo Finance • 3 days ago
Cogent Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 2 months ago
Catalyst Watch: Alphabet earnings, McGraw Hill IPO, Trump talks AI, and more robotaxi buzz
Yahoo Finance • 2 months ago
Cogent Biosciences stock hits 52-week high at 12.66 USD
Yahoo Finance • 3 months ago
Citi raises Cogent stock price target to $22 on bezuclastinib potential
About
CEO | Mr. Andrew R. Robbins M.B.A. |
CFO | Mr. John L. Green C.A., CPA |
Address | 275 Wyman Street, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 205 |
